Overview

China Stroke Primary Prevention Trial

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to confirm that enalapril maleate and folic acid tablets is more effective in preventing stroke among the patients with primary hypertension when compared to enalapril maleate.
Phase:
Phase 4
Details
Lead Sponsor:
Shenzhen Ausa Pharmed Co.,Ltd
Collaborator:
Anhui Medical University
Treatments:
Enalapril
Enalaprilat
Folic Acid
Maleic acid
Vitamin B Complex